Diane 35, also known as co-cyprindiol, is a prescription medication combining the anti-androgen cyproterone acetate and the estrogen ethinylestradiol. It is indicated for women with androgen-dependent conditions that haven't responded to other treatments. While it treats visible symptoms like skin and hair issues, it also offers contraception. However, due to its profile and risks, it requires strict medical supervision and isn't a first-line treatment.
The Primary Uses of Diane 35
Treating Androgen-Related Conditions
Diane 35 targets conditions in women caused by excessive androgens or sensitivity to them. These include:
- Severe Acne: Often prescribed for moderate to severe acne unresponsive to other treatments, showing significant improvement in studies.
- Hirsutism: Reduces excessive hair growth on the face, chest, and back by counteracting androgen effects.
- Polycystic Ovary Syndrome (PCOS): Helps regulate hormone levels in women with PCOS experiencing symptoms like acne, hirsutism, and irregular periods due to hyperandrogenism.
The Contraceptive Function
Diane 35 also effectively prevents pregnancy by inhibiting ovulation, thickening cervical mucus, and thinning the uterine lining. However, it should not be used solely for birth control due to its higher risk profile compared to other contraceptives.
Mechanism of Action: How Diane 35 Works
- Cyproterone Acetate (CPA): This anti-androgen blocks androgen receptors and suppresses ovarian androgen production.
- Ethinylestradiol (EE): This estrogen increases sex hormone-binding globulin (SHBG), which binds to free androgens, reducing their impact. EE also helps suppress ovulation.
Important Considerations and Risks
Significant risks and contraindications are associated with Diane 35:
- Venous Thromboembolism (VTE): Increased risk of blood clots, potentially leading to DVT or PE, higher than with some other contraceptive pills, especially in the first year.
- Arterial Thromboembolism: Also increases risk of arterial clots, raising the chance of heart attack or stroke, particularly in women with existing risk factors.
- Liver Tumors: Rare reports of benign and malignant liver tumors in users of hormonal contraceptives like Diane 35.
- Meningioma: Higher doses of cyproterone acetate increase the risk of this non-cancerous brain tumor.
- Contraindications: Should not be used by women with a history of blood clots, severe liver disease, certain cancers, uncontrolled high blood pressure, or severe diabetes with vascular issues.
Comparison of Diane 35 and Alternative Treatments
Feature | Diane 35 (Cyproterone Acetate/Ethinylestradiol) | Drospirenone-Based Pills (e.g., Yaz) | General Combined Oral Contraceptives (COCs) | Other Options (IUDs, non-hormonal) |
---|---|---|---|---|
Anti-androgenic Potency | High, particularly effective for severe hirsutism and acne. | Moderate; effective for mild to moderate androgenic symptoms. | Varies depending on the progestin used; some are more androgenic. | Not applicable; no hormonal effect. |
Contraceptive Effectiveness | Highly effective when taken correctly, over 99% with perfect use. | Very effective, >99% with perfect use. | Very effective, >99% with perfect use. | Highly effective options exist (e.g., hormonal IUD), but lower efficacy rates are possible with user-dependent methods. |
Risk of Venous Thromboembolism (VTE) | Increased risk, estimated at 1.5 to 2 times higher than levonorgestrel-containing COCs. | Increased risk; similar or slightly lower than Diane 35, higher than older COCs. | Varies based on formulation; older 'second-generation' pills (levonorgestrel) have lower risk. | Copper IUDs have no VTE risk. Hormonal IUDs and injections may have minimal risk. |
Ideal Use Case | Severe androgenic symptoms unresponsive to other treatments, and contraception is required. | Management of mild to moderate acne, hirsutism, and PCOS symptoms. | General contraception and management of moderate menstrual symptoms. | Women with contraindications to hormonal contraception or those who prefer non-hormonal methods. |
Conclusion
Diane 35 is specifically used to treat severe, hormonally driven conditions in women like refractory acne, hirsutism, and certain PCOS symptoms. Its anti-androgenic and contraceptive effects make it valuable when other treatments fail. However, the increased risk of blood clots necessitates informed patient consent and careful monitoring. Since it's not for contraception alone, doctors must weigh benefits and risks, as safer alternatives may be suitable for some patients.